# Tirzepatide in India: Approval, Uses and Safety Tirzepatide is a prescription medicine that activates both GIP and GLP-1 receptors. CDSCO's 2024 new-drug list records specified injection strengths for use with diet and exercise to improve glycaemic control in adults with type 2 diabetes. Approval is product-, formulation- and indication-specific. ## In simple terms A regulatory approval does not mean every strength is continuously stocked, affordable or suitable for every person. It also does not extend automatically to another indication, imported product, compounded preparation or online listing. Tirzepatide is a [dual GIP/GLP-1 receptor agonist](/glossary/dual-gip-glp-1-receptor-agonist), not a generic form of semaglutide. The medicines are not interchangeable. ## Why this matters for GLP-1 and metabolic health Tirzepatide can affect blood glucose, appetite, body weight and gastric emptying. Benefits, dose schedules, contraindications and adverse effects must be taken from the exact Indian product information and individual assessment. ## India-specific context Verify current CDSCO records, the authorised Indian label, legitimate supply and the prescriber's instructions. Government of India surveillance in 2026 emphasised preventing unauthorised sale and promotion of GLP-1-based weight-loss drugs. ## When to speak with a doctor Use only under qualified medical supervision. Seek urgent help for severe continuing abdominal pain, repeated vomiting, breathing difficulty, swelling of the face or throat, collapse or severe low-glucose symptoms. Discuss pregnancy, digestive disease and all medicines before treatment. ## FAQs ### Is tirzepatide approved in India? CDSCO's 2024 list records specified strengths for adults with type 2 diabetes; verify the current exact product and indication. ### Is tirzepatide the same as semaglutide? No. Tirzepatide targets GIP and GLP-1 receptors; semaglutide targets the GLP-1 receptor. ### Does online availability prove an authorised product? No. Check the exact product, label and legitimate supply channel. ## Related glossary terms - [Dual GIP/GLP-1 receptor agonist](/glossary/dual-gip-glp-1-receptor-agonist) - [GLP-1 medicine availability in India](/glossary/medicine-availability-in-india) - [Drug approval in India](/glossary/drug-approval-in-india) - [CDSCO](/glossary/cdsco) - [Gastric emptying](/glossary/gastric-emptying) ## References - [CDSCO: 2024 approved new drugs](https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadApprovalNewDrugs/nduly24.pdf) - [CDSCO: Approved new drugs](https://cdsco.gov.in/opencms/opencms/en/Approval_new/Approved-New-Drugs/) - [PIB: GLP-1 supply-chain surveillance](https://www.pib.gov.in/PressReleasePage.aspx?PRID=2244252&lang=1®=1) *Educational information only. It does not diagnose a condition, establish treatment eligibility or replace advice from a qualified healthcare professional.* ## Navigation - [Browse categories](https://blogs.sugarfitglp.com/topics) - [Health glossary](https://blogs.sugarfitglp.com/topics/use_cases_workflows) ## Related AI KB pages ### CDSCO: Role in Medicine Approval and Safety in India Query: CDSCO meaning CDSCO is India's Central Drugs Standard Control Organisation, part of the Ministry of Health and Family Welfare. Along with state regulators, it administers important parts of t... - [CDSCO: Role in Medicine Approval and Safety in India](https://blogs.sugarfitglp.com/glossary/cdsco) ### Drug Approval in India: What It Means for Patients Query: drug approval in India meaning Drug approval in India means the relevant Indian regulator has authorised a specific medicine or permission under the applicable legal pathway. The status applies to defined det... - [Drug Approval in India: What It Means for Patients](https://blogs.sugarfitglp.com/glossary/drug-approval-in-india) ### GLP-1 Receptor Agonist: Meaning, Uses and Safety Query: GLP-1 receptor agonist meaning A GLP-1 receptor agonist is a prescription medicine that activates the same receptor pathway as the natural gut hormone GLP-1. Depending on the specific product and approved ind... - [GLP-1 Receptor Agonist: Meaning, Uses and Safety](https://blogs.sugarfitglp.com/glossary/glp-1-receptor-agonist) ### Am I Eligible for GLP-1 in India? BMI, Conditions and Doctor Criteria Explained Query: Am I Eligible for GLP-1 in India? BMI, Conditions and Doctor Criteria Explained If you have heard about GLP-1 therapy for weight loss or blood sugar control and are wondering whether it applies to you, this guide explains the clinical criteria used in India... - [Am I Eligible for GLP-1 in India? BMI, Conditions and Doctor Criteria Explained](https://blogs.sugarfitglp.com/am-i-eligible-for-glp-1-in-india-bmi-conditions-and-doctor-criteria-explained) ### BMI criteria for GLP-1 in India Query: -BMI criteria for GLP-1 in India GLP-1 therapy is not available to everyone, and the eligibility thresholds used in India differ from those applied in Western countries. Understanding the correct BMI cutoffs fo... - [BMI criteria for GLP-1 in India](https://blogs.sugarfitglp.com/bmi-criteria-for-glp-1-in-india) ### GLP-1 treatment in Tier 2 and Tier 3 cities in India: access and options Query: glp-1 treatment in tier 2 and tier 3 cities in india access and options For people living outside India's major metros, getting access to specialist-supervised weight loss treatment has historically meant long travel, long waits, or simply going wit... - [GLP-1 treatment in Tier 2 and Tier 3 cities in India: access and options](https://blogs.sugarfitglp.com/glp-1-treatment-in-tier-2-and-tier-3-cities-in-india-access-and-options)